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Abstract: 
Objective: To evaluate the hematological features of patients with helicobacter pylori infection. 
Patients And Methods: A total of fifty patients of Helicobacter pylori infection were explored and included in the 
study. The cross-sectional survey includes patients of ≥18 year of age diagnosed as H. pylori infection either gender 
while the exclusion criteria were patients with pregnant and lactating mothers, already on chemotherapy, iron and 
vitamin B12 supplements, known cases of hematological malignancy and history of blood transfusion and the 
participants who refused to give consent for the study. The hematological parameters will be explored through 
clinical history examination, physical examination and specific investigations as required whereas the frequency / 
percentages (%) and means ±SD computed for study variables.  
Results: During six month study period total fifty patients with H. pylori were explored and study. The mean ± SD 
for age (yrs) of population was 42.74±6.75. Regarding gender distribution male 35 (70%) and female 15 (30%). 
Regarding the hematological manifestation iron deficiency 25 (50%), vitamin B12 (cobalamina) deficiency 10 
(20%), Gastric MALT lymphoma 04 (8.0%) and Immune thrombocytopenia 11 (22%). 
Conclusion:The acknowledgment of hematologic infections related with H. pylori contamination and their 
consideration as signs for study. 
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INTRODUCTION: 
Helicobacter pylori (H. pylori) is a gram-negative, 
microaerophilic, winding molded and lashed 
bacterium contaminating about a large portion of the 
total populace whose principle store is the human 
stomach. The predominance of contamination 
changes by geographic territory, age, ethnicity and 
financial status; truth be told, the pervasiveness is 
higher in developing nations and in those with poor 
financial conditions[1, 2]. H. pylori has 
microbiological qualities that enable it to make due in 
incredibly unfavorable conditions, for example, the 
gastric acidic condition. Transmission of the disease 
happens essentially through the oral-fecal route [3], 
specifically through polluted water and sustenance. 
Oral-oral transmission is likewise conceivable, as 
appeared by the confinement of the bacterium in 
salivation and dental plaque. In the 30 years that have 
passed since its disclosure, more than 50 extragastric 
indications of H. pylori disease have been accounted 
for, including a scope of medicinal specializations 
including dermatology, gynecology and obstetrics, 
cardiology, endocrinology, pulmonology, 
ophthalmology, otorhinolaryngology, nervous system 
science, pediatric medicine, odontology and 
hematology [4-6]. Hematological signs are the 
subject of this audit. Hematological pattern that are 
perceived as extragastric appearances of H. pylori 
disease and considered as hematological dysfunction 
that ought not be just tended to but rather needs to 
oversee on need premise to counteract the patient 
procure perilous inconveniences. 
 
PATIENTS AND METHODS: 
A total of fifty patients of Helicobacter pylori 
infection were explored and included in the study. 
The cross-sectional survey includes patients of ≥18 
year of age diagnosed as H. pylori infection either 
gender while the exclusion criteria were patients with 
pregnant and lactating mothers, already on 
chemotherapy, iron and vitamin B12 supplements, 
known cases of hematological malignancy and 
history of blood transfusion and the participants who 
refused to give consent for the study. The 
hematological parameters will be explored through 
clinical history examination, physical examination 
and specific investigations as required. The data was 
collected on pre-designed proforma and analyzed in 
SPSS to manipulate the frequencies and percentages. 
 
RESULTS: 
During six month study period total fifty patients 
with H. pylori were explored and study. The mean ± 
SD for age (yrs) of population was 42.74±6.75. The 
demographical and clinical profile of study 
population is presented in Table 1. 
 
TABLE 1: The Demographical And Clinical Profile Of Study Population 
Parameter Frequency (N=50) Percentage (%) 
AGE (yrs) 
20-29 10 20 
30-39 12 24 
40-49 14 28 
50-59 08 16 
60+ 06 12 
GENDER 
Male 35 70 
Female 15 30 
RESIDENCE 
Urban 29 58 
Rural 21 42 
CO-MORBIDITIES 
Obesity 22 44 
Dyslipidemia 12 24 
Diabetes Mellitus 20 40 
Hypertension 18 36 
HEMATOLOGICAL MANIFESTATION 
Iron deficiency 25 50 
Vitamin B12 (cobalamina) deficiency 10 20 
Gastric MALT lymphom 04 8.0 
Immune thrombocytopenia 11 22 
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DISCUSSION:  
The connection between H. pylori and iron lacks, 
paying little respect to whether the last is joined by 
pallor, was first portrayed by Blecker et al[7] in 
Belgium. All previous distribution have loaned 
logical help to the diverse worldwide rules that show 
that H. pylori ought to be looked for and destroyed in 
iron lack cases. Pernicious anemia as a phase of 
interminable nutrient B12 deficient was the first 
extragastric infection to be related with H. pylori 
disease, as hypothesized in established researchers by 
O'Connor et al [8]. Also, it was realized that there 
was a relationship of H. pylori with stomach disease, 
and it was at that point broadly perceived by 
mainstream researchers that that pernicious anemia 
was firmly identified with the advancement of 
stomach cancer[9]. This affiliation was as of late 
checked by Vanella et al[10]. Garcia Perez et al [11] 
depicted the relationship of H. pylori with immune 
thrombocytopenic purpura without precedent for 
1993 in Spain, detailing a patient with immune 
thrombocytopenic purpura in whom the platelet tally 
was standardized after annihilation of H. pylori. 
Since the main arrangement substantiated the 
relationship of H. pylori contamination with immune 
thrombocytopenic purpura [12], it is conceivable to 
discover 40 extra case arrangements in the 
therapeutic writing in 2014 that reliably demonstrate 
the relationship of H. pylori annihilation with the 
recuperation of platelet tallies. Extranodal minimal 
zone lymphoma, better known by the abbreviation 
MALT lymphoma, is characterized as a poor quality 
harmful lymphoma of the stomach starting from B 
cells and is related with constant disease by H. 
pylori[13]. 
 
CONCLUSION: 
The acknowledgment of hematologic infections 
related with H. pylori contamination and their 
consideration as signs for study and destruction 
speaks to a profound change in the treatment 
worldview of these illnesses and an incredible 
achievement for humanity 
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